Literature DB >> 12181247

Management of women with ductal carcinoma in situ of the breast: a population-based study.

H M Verkooijen1, G Fioretta, C De Wolf, G Vlastos, J Kurtz, B Borisch, P Schäfer, A Spiliopoulos, A P Sappino, R Renella, B Pittet, J Schmid De Gruneck, Y Wespi, I Neyroud-Caspar, C Bouchardy.   

Abstract

BACKGROUND: Increasing incidence of ductal carcinoma in situ (DCIS) confronts patients and clinicians with optimal treatment decisions. This multidisciplinary study investigates therapeutic modalities of DCIS in daily practice and provides recommendations on how to increase quality of care. PATIENTS AND METHODS: All women (n = 116) with unilateral DCIS recorded in the Geneva Cancer Registry from 1995 to 1999 were considered. Information concerned patient and tumor characteristics, treatment and outcome. Factors linked to therapy were determined using a case-control approach. Cases were women with treatment of interest and controls other women on the study.
RESULTS: Most DCIS cases (62%) were discovered by mammography screening. Ninety (78%) women had breast-conserving surgery (BCS), 18 (16%) mastectomy and seven (6%) bilateral mastectomy. Eight (7%) patients had tumor-positive margins, 18 (16%) lymph node dissection and two (1.7%) chemotherapy. Twenty-five per cent of women with BCS had no radiotherapy, three had radiotherapy after mastectomy. Less than 50% underwent breast reconstruction after mastectomy. Method of discovery, multifocality, tumor localization, size and differentiation were linked to the use of BCS or lymph node dissection.
CONCLUSIONS: Because of important disparities in DCIS management, recommendations are made to increase quality of care, in particular to prevent axillary dissection or bilateral mastectomy and to increase the use of radiotherapy after BCS.

Entities:  

Mesh:

Year:  2002        PMID: 12181247     DOI: 10.1093/annonc/mdf194

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  4 in total

1.  Clinical experience of patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery plus radiotherapy: a preliminary report.

Authors:  Ji-Young Jang; Mi-Ryeong Ryu; Sung-Whan Kim; Chul-Seung Kay; Yeon-Sil Kim; Yoon-Kyeong Oh; Hyung-Chul Kwon; Sei-Chul Yoon; Woo-Chan Park; Byung-Joo Song; Se-Jeong Oh; Sang-Seol Jung; Jong-Man Won; Seung-Nam Kim; Su-Mi Chung
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

2.  Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.

Authors:  M Jacob Adams; Ann Dozier; Roy E Shore; Steven E Lipshultz; Ronald G Schwartz; Louis S Constine; Thomas A Pearson; Marilyn Stovall; Paul Winters; Susan G Fisher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

3.  Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ.

Authors:  M A J de Roos; G H de Bock; P C Baas; L de Munck; T Wiggers; J de Vries
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

4.  A nation-wide multicenter retrospective study of the epidemiological, pathological and clinical characteristics of breast cancer in situ in Chinese women in 1999 - 2008.

Authors:  Yanan Kong; Lu Yang; Hailin Tang; Ning Lv; Xinhua Xie; Jing Li; Jiaoli Guo; Laisheng Li; Minqin Wu; Jie Gao; Hongjian Yang; Zhonghua Tang; Jianjun He; Bin Zhang; Hui Li; Youlin Qiao; Xiaoming Xie
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.